The maker of Makena, an unproven drug intended to prevent premature births, says it will voluntarily remove the product from the U.S. after regulators signaled plans to follow through on a long-delayed effort to force it from the market.
This image provided by Covis Pharma shows packaging for the company's Makena medication. The maker of an unproven drug intended to prevent premature births says it will voluntarily remove the product from the U.S. market, after regulators signaled plans to follow through on a long-delayed effort to force it from the market.
WASHINGTON — The maker of an unproven drug intended to prevent premature births says it will voluntarily remove the product from the U.S., after regulators signaled plans to follow through on a long-delayed effort to
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Maker of preterm birth drug Makena to withdraw it from market | CNNThe maker of the drug Makena, which was approved more than a decade ago to reduce the risk of preterm birth, said Tuesday that it is moving to withdraw the medication from the market after a US Food and Administration panel said it is not effective.
Read more »
Maker of unproven birth drug Makena to pull from US marketThe maker of an unproven drug intended to prevent premature births says it will voluntarily remove the product from the United States
Read more »
FBI Says 4 US Citizens Missing After Being Assaulted, Kidnapped in MexicoFBI Says 4 US Citizens Missing After Being Assaulted, Kidnapped in Mexico | Compare reporting by Reuters dcexaminer washingtonpost
Read more »
Drug to Prevent Preterm Births to Be Pulled From MarketThe maker of Makena said it will stop selling the drug to prevent preterm births after a study couldn’t confirm the medicine worked
Read more »
Marlboro maker Altria agrees to buy e-cigarette startup NJOY for nearly $2.8 billionAltria's deal to buy NJOY comes after the Marlboro maker exited its position in Juul Labs.
Read more »
Altria buying vape maker NJOY for $2.75BAltria will buy vape-maker NJOY and absorb the company’s NJOY ACE production as the only e-vapor product with market authorizations from the U.S. Food and Drug Administration (FDA).
Read more »